Funding Received
$3.5 Million in 1 Round from 2 Investors
Most Recent Funding
$3.5 Million Series A on June 26, 2013
Founded:
2008
Headquarters:
Menlo Park, CA
Description:
NuMedii discovers and de-risks effective drugs by translating life sciences big data into therapies.
Founders:
Gini Deshpande
Categories:
Biotechnology
Website:
http://numedii.com

Detailed Description

Update

NuMedii discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies with a higher probability of therapeutic success. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of millions of raw human, biological, pharmacological and clinical data points that the company has normalized and annotated. The company integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases.

Current Team (3)

Update

Funding Rounds (1) - $3.5M

Update

Investors (2)

Update

Offices/Locations (1)

Update
  • Office

    PO Box 7381

    Menlo Park, CA 94026

    USA

Images (1)

Update
  • 4246df6a3d9a5c8149013c7dbb699b3a